Wolverine Asset Management’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Wolverine Asset Management’s Portfolio NWBOW Stock Details NWBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,500	Closed	–	–	1454
2016 Q3	$0	Buy	1,500 +1,000	+200%	+$286	﹤0.01%	1469
2016 Q2	$0	Buy	500 +400	+400%	+$238	﹤0.01%	1471
2016 Q1	$0	Buy	+100	New	+$112	﹤0.01%	1909

Other funds holding NWBOW

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Wolverine Asset Management's NWBOW Position: Q4 2016 in Review

Wolverine Asset Management sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q4 2016, closing a stake of 1,500 shares.

Wolverine Asset Management first reported a position in NWBOW in Q1 2016 and held it in 3 quarters. The position peaked at $0 in Q3 2016. 1 fund tracked by Wall St. Rank holds NWBOW as of Q4 2016.

Wolverine Asset Management reported no remaining Northwest Biotherapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Wolverine Asset Management sold 1,500 Northwest Biotherapeutics, Inc. shares in Q4 2016.
Wolverine Asset Management first reported a position in Northwest Biotherapeutics, Inc. in Q1 2016 and held it in 3 quarters.
Wolverine Asset Management's Northwest Biotherapeutics, Inc. position peaked at $0 in Q3 2016.
1 fund tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.